Skip to main content

Animations

MJFF Publications

911 - 920 of 6255 Results
Title
Year
  • Year
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2022
  • Summary Details
    OPEN
    Title: Knockout or inhibition of USP30 protects dopaminergic neurons in a Parkinson’s disease mouse model
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-023-42876-1
    Citation Count: 43
  • Summary Details
    OPEN
    Title: Cross species systems biology discovers glial DDR2, STOM, and KANK2 as therapeutic targets in progressive supranuclear palsy
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-023-42626-3
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Feed-forward metabotropic signaling by Cav1 Ca2+ channels supports pacemaking in pedunculopontine cholinergic neurons
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd, cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nbd.2023.106328
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Longitudinal hippocampal subfields, CSF biomarkers, and cognition in patients with Parkinson disease
    Journal Name: Clinical Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.prdoa.2023.100199
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Internal tremor in people with Parkinson’s Disease: Demographic characteristics and comorbid symptoms
    Journal Name: Clinical Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.prdoa.2023.100229
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Cerebrospinal fluid biomarkers profile in scans without evidence of dopaminergic deficits (SWEDD)
    Journal Name: IBRO Neuroscience Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.ibneur.2023.10.001
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Transforming Drug Development for Neurological Disorders: Proceedings from a Multidisease Area Workshop
    Journal Name: Neurotherapeutics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1007/s13311-023-01440-x
    Citation Count: 15
  • Summary Details
    OPEN
    Title: 13C and 15N resonance assignments of alpha synuclein fibrils amplified from Lewy Body Dementia tissue
    Journal Name: Biomolecular NMR Assignments
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s12104-023-10156-0
    Citation Count: 4
  • Summary Details
    OPEN
    Title: SOD1-Related Cerebellar Ataxia and Motor Neuron Disease: Cp Variant as Functional Modifier?
    Journal Name: The Cerebellum
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s12311-023-01527-3
    Citation Count: 3
  • Summary Details
    OPEN
    Title: ThX: a next generation probe for the early detection of amyloid aggregates
    Journal Name: Biophysical Journal
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1016/j.bpj.2021.11.2608
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.